news roundup
Factory-CRO Group, a global CRO and Boston Biomedical Associates (BBA), a full-service Medical Device/Biotechnology CRO and Consultancy announced that they have merged the organizations.
Advertisement
Tell us what you think about clinical operations and receive a $5 Amazon gift card!
Take the short survey |
LabConnect, a global provider of central laboratory and support services, is pleased to announce a new service: LabConnect's global sample processing network (GSPN). This GSPN will offer a global solution for sample preparation and processing requirements.
Advertisement
Introducing Cross-Trial LMS: A Simple, Efficient, and Intuitive Way to Send Bulk Training
On Demand
Read More |
PHARMASEAL, a new provider of clinical trial management and governance solutions, has launched Engility CTMS, the first product to be released from its Engility B2B platform. This new CTMS has been designed in hopes to increase the level of governance and control that organizations demand from their management systems to enable effective oversight of their clinical trials.
Clinical services provider International Drug Development Institute (IDDI) is forming a research collaborative into the use of a new statistical method called Generalized Pairwise Comparisons (GPC). The objective of the collaborative is to establish proof of the concept that the GPC method can complement traditional methods for the design, analysis and interpretation of clinical trial results in regard to accounting for multiple endpoints at once and ranked in order of priority. In addition to IDDI's lead, the collaborative includes Bristol-Myers Squibb, the European Organization for Research and Treatment of Cancer (EORTC), the Université Catholique de Louvain and the University Hospital and Cancer Center of Lyon.
|
|